CX-516
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameCX-516
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRespirerx Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRespirerx Pharmaceuticals IncNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive Indications +[6]